» Articles » PMID: 31579438

Emerging Insights into the Biology of Metastasis: A Review Article

Overview
Specialty General Medicine
Date 2019 Oct 4
PMID 31579438
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis means the dissemination of the cancer cells from one organ to another which is not directly connected to the primary site. Metastasis has a crucial role in the prognosis of cancer patients. A few theories, different types of cell and several molecular pathways have been proposed to explain the mechanism of metastasis. In this work, the related articles in the limited period of time, 2000-mid -2018 were reviewed, through search in PubMed, Google Scholar and Scopus database. The articles published in the last two decades related to the biology of cancer metastasis were selected and the most important factors were discussed. Metastasis is critical factor to predict survival in patients with advanced cancer and prognosis determines the treatment plan. Many different cell types and various signaling pathways control the metastatic process. Metastasis is a multistep process. Many signaling pathways and molecules are involved in metastasis. Increasing knowledge about the mechanism of metastasis can help in finding the promising targets of cancer therapy.

Citing Articles

Mechanical deformation and death of circulating tumor cells in the bloodstream.

Qiu Y, Gao T, Smith B Cancer Metastasis Rev. 2024; 43(4):1489-1510.

PMID: 38980581 PMC: 11900898. DOI: 10.1007/s10555-024-10198-3.


Role of Phytoconstituents in Cancer Treatment: A Review.

Kumar M, Gupta S, Kalia K, Kumar D Recent Adv Food Nutr Agric. 2024; 15(2):115-137.

PMID: 38369892 DOI: 10.2174/012772574X274566231220051254.


Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?.

Wilczynski J, Paradowska E, Wilczynski M J Pers Med. 2024; 14(1).

PMID: 38248751 PMC: 10817599. DOI: 10.3390/jpm14010049.


LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis.

Mazarei M, Rabori V, Ghasemi N, Salehi M, Rayatpisheh N, Jahangiri N Clin Exp Med. 2023; 23(8):4457-4472.

PMID: 37695391 DOI: 10.1007/s10238-023-01179-x.


"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.

Wilczynski J, Wilczynski M, Paradowska E Front Oncol. 2023; 13:1201497.

PMID: 37448521 PMC: 10338102. DOI: 10.3389/fonc.2023.1201497.


References
1.
Umer M, Vaidyanathan R, Nguyen N, Shiddiky M . Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies. Biotechnol Adv. 2018; 36(4):1367-1389. DOI: 10.1016/j.biotechadv.2018.05.002. View

2.
Angara K, Borin T, Arbab A . Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma. Transl Oncol. 2017; 10(4):650-660. PMC: 5496207. DOI: 10.1016/j.tranon.2017.04.007. View

3.
Kudo-Saito C . Cancer-associated mesenchymal stem cells aggravate tumor progression. Front Cell Dev Biol. 2015; 3:23. PMC: 4381695. DOI: 10.3389/fcell.2015.00023. View

4.
Paoli P, Giannoni E, Chiarugi P . Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013; 1833(12):3481-3498. DOI: 10.1016/j.bbamcr.2013.06.026. View

5.
Pittoni P, Tripodo C, Piconese S, Mauri G, Parenza M, Rigoni A . Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res. 2011; 71(18):5987-97. DOI: 10.1158/0008-5472.CAN-11-1637. View